Matches in Wikidata for { <http://www.wikidata.org/entity/Q95504413> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q95504413 description "article by Angela Moore et al published 1 January 2014 in Journal of Drugs in Dermatology" @default.
- Q95504413 description "article scientifique publié en 2014" @default.
- Q95504413 description "im Jahr 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95504413 description "wetenschappelijk artikel" @default.
- Q95504413 description "наукова стаття, опублікована у 2014" @default.
- Q95504413 name "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 name "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 type Item @default.
- Q95504413 label "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 label "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 prefLabel "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 prefLabel "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 P1433 Q95504413-4E4740E9-FDEB-46F4-B138-7D33834C7F77 @default.
- Q95504413 P1476 Q95504413-35AE6E90-C020-47EB-880B-94DD2956A1FA @default.
- Q95504413 P2093 Q95504413-0C9850F3-DCF6-4090-98A6-3EA834F91BDC @default.
- Q95504413 P2093 Q95504413-1C6326F5-D847-45D7-860D-AC57E4299A5B @default.
- Q95504413 P2093 Q95504413-B36B7246-AE48-450B-9B8D-DA625CDF9BA0 @default.
- Q95504413 P2093 Q95504413-BF3C7798-A5C8-4615-8055-9B03ACA2B291 @default.
- Q95504413 P2093 Q95504413-D8DFB52D-D5F4-4903-B8A3-0851190550EF @default.
- Q95504413 P2093 Q95504413-DB43CFBE-E1FA-4E31-8E12-CDF5788527BB @default.
- Q95504413 P2093 Q95504413-E4A3DB62-3DCC-4E78-BFC2-36B060D92E21 @default.
- Q95504413 P2093 Q95504413-EA8A45F1-8B2F-4D5B-916A-2A5BE6B9A923 @default.
- Q95504413 P304 Q95504413-3BBEE3BB-76B6-4C72-8AEB-B98F6F8AC1BB @default.
- Q95504413 P31 Q95504413-F6E12B4A-1657-479B-A377-815AEC72FD7E @default.
- Q95504413 P433 Q95504413-185A4459-BFF3-4D8D-9853-D7D752B7C751 @default.
- Q95504413 P478 Q95504413-27A66DFC-7D88-41EE-BD20-065A35067BDD @default.
- Q95504413 P577 Q95504413-06503473-D349-44F7-B67A-71618DDC9693 @default.
- Q95504413 P698 Q95504413-557990BF-C4E4-4B8F-83BA-84CC22DD1210 @default.
- Q95504413 P698 24385120 @default.
- Q95504413 P1433 Q25380091 @default.
- Q95504413 P1476 "Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study" @default.
- Q95504413 P2093 "Amanda Tauscher" @default.
- Q95504413 P2093 "Angela Moore" @default.
- Q95504413 P2093 "George Murakawa" @default.
- Q95504413 P2093 "Hong Liu" @default.
- Q95504413 P2093 "Jonathan Weiss" @default.
- Q95504413 P2093 "Leonard Swinyer" @default.
- Q95504413 P2093 "Matthew Leoni" @default.
- Q95504413 P2093 "Steven Kempers" @default.
- Q95504413 P304 "56-61" @default.
- Q95504413 P31 Q13442814 @default.
- Q95504413 P433 "1" @default.
- Q95504413 P478 "13" @default.
- Q95504413 P577 "2014-01-01T00:00:00Z" @default.
- Q95504413 P698 "24385120" @default.